"10.1371_journal.pone.0013421","plos one","2010-10-20T00:00:00Z","Alaa Alkhalaf; Petra Zürbig; Stephan J L Bakker; Henk J G Bilo; Marie Cerna; Christine Fischer; Sebastian Fuchs; Bart Janssen; Karel Medek; Harald Mischak; Johannes M Roob; Kasper Rossing; Peter Rossing; Ivan Rychlík; Harald Sourij; Beate Tiran; Brigitte M Winklhofer-Roob; Gerjan J Navis; for the PREDICTIONS Group","Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands; Mosaiques diagnostics GmbH, Hannover, Germany; Department of General Biology and Genetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Institute of Human Genetics, Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany; Human Nutrition & Metabolism Research and Training Center, Institute of Molecular Biosciences, Karl Franzens University of Graz, Graz, Austria; Faculty of Medicine, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Clinical Division of Nephrology and Hemodialysis, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Steno Diabetes Center, Gentofte, Denmark; Second Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria","Conceived and designed the experiments: PZ SJB BJ HM PR IR BMWR GN. Performed the experiments: AA PZ SF KM KR HS BT. Analyzed the data: PZ CF HM. Contributed reagents/materials/analysis tools: HJB MC JMR IR BMWR GN. Wrote the paper: AA PZ SJB HM GN.","H. Mischak is co-founder and a shareholder of mosaiques diagnostics GmbH (Hannover, Germany). P. Zürbig is an employee of mosaiques diagnostics GmbH. P. Rossing has served as a consultant to Merck, Bristol-Myers Squibb and AstraZeneca, has received research grants from Novartis and has been a member of speakers bureaus sponsored by Novartis, Boehringer Ingelheim, and Sanofi-Aventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2010","10","Alaa Alkhalaf","AA",19,TRUE,8,7,3,5,TRUE,FALSE,FALSE,0,NA,FALSE
